Literature DB >> 16163348

Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.

Rainer Zenz1, Robert Eferl, Lukas Kenner, Lore Florin, Lars Hummerich, Denis Mehic, Harald Scheuch, Peter Angel, Erwin Tschachler, Erwin F Wagner.   

Abstract

Psoriasis is a frequent, inflammatory disease of skin and joints with considerable morbidity. Here we report that in psoriatic lesions, epidermal keratinocytes have decreased expression of JunB, a gene localized in the psoriasis susceptibility region PSORS6. Likewise, inducible epidermal deletion of JunB and its functional companion c-Jun in adult mice leads (within two weeks) to a phenotype resembling the histological and molecular hallmarks of psoriasis, including arthritic lesions. In contrast to the skin phenotype, the development of arthritic lesions requires T and B cells and signalling through tumour necrosis factor receptor 1 (TNFR1). Prior to the disease onset, two chemotactic proteins (S100A8 and S100A9) previously mapped to the psoriasis susceptibility region PSORS4, are strongly induced in mutant keratinocytes in vivo and in vitro. We propose that the abrogation of JunB/activator protein 1 (AP-1) in keratinocytes triggers chemokine/cytokine expression, which recruits neutrophils and macrophages to the epidermis thereby contributing to the phenotypic changes observed in psoriasis. Thus, these data support the hypothesis that epidermal alterations are sufficient to initiate both skin lesions and arthritis in psoriasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16163348     DOI: 10.1038/nature03963

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  192 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

2.  Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.

Authors:  N L Ward; C M Loyd; J A Wolfram; D Diaconu; C M Michaels; T S McCormick
Journal:  Br J Dermatol       Date:  2011-04       Impact factor: 9.302

3.  Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.

Authors:  Ling-Juan Zhang; George L Sen; Nicole L Ward; Andrew Johnston; Kimberly Chun; Yifang Chen; Christopher Adase; James A Sanford; Nina Gao; Melanie Chensee; Emi Sato; Yi Fritz; Jaymie Baliwag; Michael R Williams; Tissa Hata; Richard L Gallo
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

4.  Fra-2-expressing macrophages promote lung fibrosis in mice.

Authors:  Alvaro C Ucero; Latifa Bakiri; Ben Roediger; Masakatsu Suzuki; Maria Jimenez; Pratyusha Mandal; Paola Braghetta; Paolo Bonaldo; Luis Paz-Ares; Coral Fustero-Torre; Pilar Ximenez-Embun; Ana Isabel Hernandez; Diego Megias; Erwin F Wagner
Journal:  J Clin Invest       Date:  2019-05-28       Impact factor: 14.808

Review 5.  Animal models of psoriasis and psoriatic arthritis: an update.

Authors:  Curdin Conrad; Frank O Nestle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

6.  Calcipotriol affects keratinocyte proliferation by decreasing expression of early growth response-1 and polo-like kinase-2.

Authors:  Jernej Kristl; Petra Slanc; Metka Krasna; Ales Berlec; Matjaz Jeras; Borut Strukelj
Journal:  Pharm Res       Date:  2007-08-02       Impact factor: 4.200

Review 7.  Epidermal barrier formation and recovery in skin disorders.

Authors:  Julia A Segre
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

8.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

Review 9.  Psoriasis: advances in pathophysiology and management.

Authors:  A MacDonald; A D Burden
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

Review 10.  Altered bone remodeling in psoriatic arthritis.

Authors:  Kofi A Mensah; Edward M Schwarz; Christopher T Ritchlin
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.